Anixa biosciences stock.

Company Summary. Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation ...A list of analyst ratings for Anixa Biosciences (ANIX) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... Anixa Biosciences Analyst Ratings. All Analysts Top Analysts Total Analysts . 2. Consensus Rating . Strong Buy. Price Target . $10.50. Upside +217.22%. Ratings History.Anixa Biosciences Inc: Overview ... Anixa Biosciences Inc (Anixa) is a biotechnology company. The company develops and acquires patented technologies in the areas ...Anixa Biosciences (ANIX) Quote Overview ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. In general, a lower number or multiple is usually ...

Anixa Biosciences Stock (NASDAQ:ANIX), Dividends benzinga.com - June 20 at 11:45 PM 6 Analysts Have This to Say About Anixa Biosciences markets.businessinsider.com - June 19 at 5:36 PM HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target benzinga.com - June 19 at 7:36 AMMay 22, 2023 · SAN JOSE, Calif., May 22, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in ...

In depth view into ANIX (Anixa Biosciences) stock including the latest price, news, dividend history, earnings information and financials.Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today reassured its shareholders and the investment community that it does not ...

SAN JOSE, Calif., July 20, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that due to public health and safety concerns related to the ongoing COVID-19 global pandemic and to support the health and well-being of its stockholders, employees and others, the Company is ...Anixa Biosciences' cash burn of US$5.8m is about 5.2% of its US$113m market capitalisation. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan.Anixa Biosciences Stock Price, News & Analysis (NASDAQ:ANIX) $3.27 -0.07 (-2.10%) (As of 12/1/2023 ET) Compare Today's Range $3.25 $3.43 50-Day Range $2.85 $3.64 52-Week Range $2.75 $6.45 Volume 45,375 shs Average Volume 70,005 shs Market Capitalization $101.60 million P/E Ratio N/A Dividend Yield N/A Price Target $10.50Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial. SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National …Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.

Anixa Biosciences (ANIX) Quote Overview ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. In general, a lower number or multiple is usually ...

Aug 31, 2022 · SAN JOSE, Calif., Aug. 31, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...

Real time Anixa Biosciences (ANIX) stock price quote, stock graph, news & analysis. ... Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that ...Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial. SAN JOSE, Calif. , May 22, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in conjunction ... 6 months ago - PRNewsWire.SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining the design of its breast cancer vaccine trial at the American Society of Clinical Oncology (ASCO) Annual …Stock analysis for Anixa Biosciences Inc (ITUS:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report), with a price target of $12.00. Yi Chen has given Anixa Biosciences ...SAN JOSE, Calif., Oct. 3, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...According to the issued ratings of 2 analysts in the last year, the consensus rating for Anixa Biosciences stock is Buy based on the current 2 buy ratings for ANIX. The average twelve-month price prediction for Anixa Biosciences is $10.50 with a high price target of $12.00 and a low price target of $9.00. Learn more on ANIX's analyst rating ...Analyst Recommendations on Copytele Inc. HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating. Mar. 23. MT. Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating. Mar. 22. MT. Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target. Dec. 23.28 Sep 2018 ... The company's shares will trade on the Nasdaq Capital Market under the new stock symbol ANIX at the start of trading on Oct. 1. The name change ...SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining the design of its breast cancer vaccine trial at the American Society of Clinical Oncology (ASCO) Annual …

Anixa Biosciences (ANIX) In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences, with a price target of $12.00 . The company’s shares closed last ...

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology ... Anixa Biosciences, Inc. today announced that its partner, Cleveland Clinic, ...Discover historical prices for ANIX stock on Yahoo Finance. View daily, weekly or monthly format back to when Anixa Biosciences, Inc. stock was issued.SAN JOSE - Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National Conference taking place from November 1 - 3, 2023.Anixa Biosciences (ANIX) Quote Overview ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. In general, a lower number or multiple is usually ...Stock Information. Quote; Charts; Historical Data; Analyst Coverage. ... Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr ...A high-level overview of Anixa Biosciences, Inc. (ANIX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Detailed balance sheet for Anixa Biosciences, Inc. (ANIX), including cash, debt, assets, liabilities, and book value. ... Stock Analysis Pro. Watchlist. Collapse. Anixa Biosciences, Inc. (ANIX) NASDAQ: ANIX · IEX Real-Time Price · USD. Add to Watchlist 3.27-0.07 (-2.10%)What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock (Zacks) May-22-23 08:30AM Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire) Apr-25-23 09:40AM ... Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that …Jul 31, 2023 · The impact on the company’s stock price was immediate, with ANIX stock experiencing a slight increase of $0.13 during trading on Friday before closing at $3.68. Despite the brief upswing in its stock price, Anixa Biosciences remains embroiled in an intricate web of market uncertainties. Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Anixa Biosciences stock is Buy based on the current 2 buy ratings for ANIX. The average twelve-month price prediction for Anixa Biosciences is $10.50 with a high price target of $12.00 and a low price target of $9.00. Learn more on ANIX's analyst rating ...

Analyst's Opinion · Consensus Rating. Anixa Biosciences has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' consensus ...

The latest price target for Anixa Biosciences ( NASDAQ: ANIX) was reported by HC Wainwright & Co. on Tuesday, August 29, 2023. The analyst firm set a price target for 12.00 expecting ANIX to rise ...

During the same time frame, the estimate for Anixa Biosciences’ 2024 loss per share has remained constant at 37 cents. Year to date, shares of ANIX have lost 32.2%.In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report), with a price target of $12.00. Yi Chen has given Anixa Biosciences ...Anixa Biosciences, Inc. Appoints Mark A. Goldberg, Md, to Its Cancer Business Advisory Board CI Oct. 13: Anixa Biosciences, Inc. Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial CIView the latest Anixa Biosciences Inc. (ANIX) stock price, news, historical charts, analyst ratings and financial information from WSJ. 13 Mar 2023 ... About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's ...Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in partnership with Moffitt ...Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ANIX Stock Performance. USD USD; Previous close: 3.34: 3.34: Day range: 3.25 - 3.433.25 - 3.43Year range: 2 - 62 - 6Last Funding Type Grant; Also Known As ITUS Corporation; Legal Name CopyTele, Inc. Stock Symbol NASDAQ:ANIX; Company Type For Profit. Phone Number 6315495974.

Last Funding Type Grant; Also Known As ITUS Corporation; Legal Name CopyTele, Inc. Stock Symbol NASDAQ:ANIX; Company Type For Profit. Phone Number 6315495974.H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report) today and set a price target of $11.00. The company’s shares closed yesterday at $4.21.Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board October 23, 2023 Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical TrialInstagram:https://instagram. commercial property crowdfundingxfltdoes the iphone 15 pro have a glass backpersonal stock portfolio Track Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors swing sets at bj'sforex trader signals Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others. draft king stock price Mar 22, 2021 · Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock. News provided by. Anixa Biosciences, Inc. 22 Mar, 2021, 17:18 ET. SAN JOSE, Calif., March 22, 2021 /PRNewswire ... Anixa Biosciences, Inc. Stock technical analysis with dynamic chart and Real-time | BOERSE MUENCHEN: CY71 | BOERSE MUENCHEN 68.IWv0yX1ksJPFtk42eUQRWNQ-uhNUxqWNmPevcaQW8y4.RgairzcK2qGd4TsDDiJ3YYBc9yUTtc …